Michael A. Narachi
2015
In 2015, Michael A. Narachi earned a total compensation of $3.5M as President, Chief Executive Officer and Member of the Board of Directors at Orexigen Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $321,674 |
|---|---|
| Option Awards | $2,529,231 |
| Salary | $659,844 |
| Other | $8,466 |
| Total | $3,519,215 |
Narachi received $2.5M in option awards, accounting for 72% of the total pay in 2015.
Narachi also received $321.7K in non-equity incentive plan, $659.8K in salary and $8.5K in other compensation.
Rankings
In 2015, Michael A. Narachi's compensation ranked 2,579th out of 13,638 executives tracked by ExecPay. In other words, Narachi earned more than 81.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,579 out of 13,638 | 81st |
Division Manufacturing | 912 out of 5,187 | 82nd |
Major group Chemicals And Allied Products | 334 out of 1,857 | 82nd |
Industry group Drugs | 263 out of 1,531 | 83rd |
Industry Pharmaceutical Preparations | 208 out of 1,179 | 82nd |
Source: SEC filing on May 30, 2017.
Narachi's colleagues
We found five more compensation records of executives who worked with Michael A. Narachi at Orexigen Therapeutics in 2015.
2015
Thomas Cannell
Orexigen Therapeutics
Chief Operating Officer
2015
Joseph Hagan
Orexigen Therapeutics
Former Chief Business and Financial Officer
2015
Preston Klassen
Orexigen Therapeutics
Executive Vice President, Global Product Development
2015
Heather Turner
Orexigen Therapeutics
General Counsel
2015
Thomas Lynch
Orexigen Therapeutics